Jo Bal
- Vilanterol, a novel inhaled long-acting β2 adrenoceptor agonist (LABA), demonstrates extensive first pass clearance to metabolites with negligible pharmacological activity in manBy Andy Harrell, Sarah Siederer, Jo Bal and Rodger KempsfordAndy Harrell1Drug Metabolism and Pharmacokinetics, GlaxoSmithKline R&D, Ware, Herts, United KingdomSarah Siederer2Drug Discovery - Quantitative Sciences, GlaxoSmithKline R&D, Stevenage, Herts, United KingdomJo Bal3Clinical Pharmacology Science Support & Operations, GlaxoSmithKline R&D, Stockley Park, Middlesex, United KingdomRodger Kempsford4Medicines Development, GlaxoSmithKline R&D, Stevenage, Herts, United Kingdom
- The efficacy of inhaled fluticasone furoate (FF) and vilanterol (VI) administered in combination in asthma is comparable when administered in the morning or eveningBy Rodger Kempsford, Amanda Oliver, Lee Tombs and Jo BalRodger Kempsford1Respiratory Medicines Development Centre, GlaxoSmithKline, Stevenage, United KingdomAmanda Oliver2Respiratory & Immuno-Inflammation MDC, GlaxoSmithKline, Uxbridge, United KingdomLee Tombs3Synergy Statistics & Programming, GlaxoSmithKline, Uxbridge, United KingdomJo Bal4Clinical Pharmacology Science and Study, GlaxoSmithKline, Uxbridge, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.